Medistim ASA (LON:0OCD)
London flag London · Delayed Price · Currency is GBP · Price in NOK
208.00
-3.00 (-1.42%)
Mar 23, 2026, 8:21 AM GMT

Medistim ASA Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
699.77562.6526.36491.94427.28
Revenue Growth (YoY)
24.38%6.88%7.00%15.13%17.66%
Cost of Revenue
128.17113.68112.28106.4997.11
Gross Profit
571.59448.92414.08385.45330.16
Selling, General & Admin
230.34185.11162.6146.38134.51
Depreciation & Amortization Expenses
24.8324.5123.6623.2923.43
Other Operating Expenses
120.23101.7991.1368.8646.49
Operating Income
196.2131.08131.44141.25116.28
Interest Income
27.511.517.1216.558.17
Interest Expense
-16.85-8.33-13.35-11.75-10.38
Total Non-Operating Income (Expense)
10.653.173.774.8-2.21
Pretax Income
206.85134.25135.21146.05114.07
Provision for Income Taxes
47.6430.4131.3932.0823.17
Net Income
159.21103.83103.82113.9790.9
Net Income to Common
159.21103.83103.82113.9790.9
Net Income Growth
53.33%0.01%-8.91%25.38%31.00%
Shares Outstanding (Basic)
1818181818
Shares Outstanding (Diluted)
1818181818
Shares Change (YoY)
-0.21%0.10%0.10%0.15%0.07%
EPS (Basic)
8.715.675.686.254.99
EPS (Diluted)
8.715.675.676.244.98
EPS Growth
53.62%--9.13%25.30%31.05%
Free Cash Flow
191.57137.04102.8104.24119.97
Free Cash Flow Growth
39.80%33.30%-1.38%-13.11%79.91%
Free Cash Flow Per Share
10.487.485.625.706.57
Dividends Per Share
8.0006.0004.5004.5003.750
Dividend Growth
33.33%33.33%-20.00%25.00%
Gross Margin
81.68%79.79%78.67%78.35%77.27%
Operating Margin
28.04%23.30%24.97%28.71%27.21%
Profit Margin
22.75%18.46%19.72%23.17%21.27%
FCF Margin
27.38%24.36%19.53%21.19%28.08%
EBITDA
212.21155.59155.1164.54139.71
EBITDA Margin
30.33%27.65%29.47%33.45%32.70%
EBIT
196.2131.08131.44141.25116.28
EBIT Margin
28.04%23.30%24.97%28.71%27.21%
Effective Tax Rate
23.03%22.66%23.21%21.96%20.31%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.